Synopsis of recent research by authors named "Mayuko Chikamatsu"
- Mayuko Chikamatsu's recent research focuses on innovative therapeutic approaches for metabolic disorders, particularly non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), utilizing albumin-fusion technology to enhance drug stability and effectiveness.
- Her studies highlight the role of advanced oxidation protein products in chronic kidney disease (CKD) and how they contribute to adipose inflammation, linking metabolic symptoms to underlying systemic changes.
- Chikamatsu’s work also includes the exploration of immunotherapeutic strategies, such as the development of cell-penetrating albumin for improved antigen delivery, demonstrating a significant advance in oral immunotherapy applications.*
